IPP Bureau
Sigachi Industries unveils new products PureCoat and UltraMod
By IPP Bureau - August 21, 2024
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
Aayush Wellness enters nutraceutical market with Dreamy Sleep Gummies
By IPP Bureau - August 21, 2024
Antara AGEasy celebrates one year of advancing senior health solutions
By IPP Bureau - August 21, 2024
AGEasy has made significant strides in addressing the pressing health concerns of seniors in India
Indoco Remedies receives final ANDA approval from the USFDA for Lofexidine Tablets 0.18 mg
By IPP Bureau - August 21, 2024
This product will be manufactured by Indoco at its manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa in India
Procter & Gamble Health reports Q4 sales at Rs. 277 Cr
By IPP Bureau - August 21, 2024
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
Coveris ramps up security label protection to tackle retail theft and supply-chain protection
By IPP Bureau - August 21, 2024
Coveris’ security labels also work seamlessly with self-checkouts where around 80% of retail sales now typically occur
Ashland Rad-Sure indicators approved by AABB Standards-Compliant product program
By IPP Bureau - August 21, 2024
Rad-Sure blood irradiation indicators are FDA 510 (k) cleared medical devices that offer positive visual verification of irradiation at the minimum specified dose
Sequent Scientific receives WHO prequalification approval for Albendazole API
By IPP Bureau - August 20, 2024
This is in partnership with Mepro Pharmaceuticals which have successfully developed and commercialised the Albendazole Chewable formulation
Health Minister Nadda inaugurates ‘First Policy Makers’ Forum’ in New Delhi
By IPP Bureau - August 20, 2024
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
Granules India receives ANDA approval for Glycopyrrolate Oral Solution
By IPP Bureau - August 20, 2024
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
Health Minister Nadda reviews Monkeypox situation and preparedness
By IPP Bureau - August 19, 2024
Monkeypox infections are usually self-limiting lasting between 2-4 weeks and patients generally recover with supportive management
Health Ministry assures doctors of all possible efforts to ensure safety
By IPP Bureau - August 19, 2024
A committee to be formed to suggest measures for ensuring the safety of healthcare professionals
CIDSCON 2024 discusses actionable efforts to tackle antimicrobial resistance
By IPP Bureau - August 19, 2024
The emergence of new infections in India is a growing concern
ANVISA completes inspection at Caplin Steriles' facility at Gummidipoondi
By IPP Bureau - August 19, 2024
